Autor: |
Daniela Graham, Philip S Helliwell, Christopher Ritchlin, Alexis Ogdie, Jon T Giles, Rebecca Germino, Lori Stockert, Pamela Young, Wael Joseph, Rajiv Mundayat, Juan J Gómez-Reino |
Jazyk: |
angličtina |
Rok vydání: |
2021 |
Předmět: |
|
Zdroj: |
RMD Open, Vol 7, Iss 1 (2021) |
Druh dokumentu: |
article |
ISSN: |
2056-5933 |
DOI: |
10.1136/rmdopen-2020-001486 |
Popis: |
Objectives This post-hoc analysis explored the impact of body mass index (BMI) on tofacitinib efficacy/safety in patients with active psoriatic arthritis (PsA).Methods Data were pooled from two phase 3 studies (NCT01877668; NCT01882439). Analyses included patients randomised to tofacitinib 5/10 mg two times a day or placebo, stratified by baseline BMI: |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|